Editorial comments on: Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder, by E. Kaasinen et al. (in this issue).
作者信息
Esuvaranathan Kesavan
机构信息
a Department of Urology , National University of Singapore , Singapore.